Skip to Content
Dr. Paul explains MS to the newly diagnosed. Watch video >>

Daclizumab Pregnancy and Breastfeeding Warnings

Daclizumab is also known as: Zenapax, Zinbryta

Daclizumab Pregnancy Warnings

Daclizumab has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted. There are no controlled data in human pregnancy. IgG molecules have been reported to cross the placental barrier. Daclizumab should only be given during pregnancy when benefits outweigh risks. It is recommended that women of childbearing potential use effective contraception before beginning daclizumab therapy, during therapy, and for four months after the completion of therapy.

See references

Daclizumab Breastfeeding Warnings

There are no data on the excretion of daclizumab into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to daclizumab in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Zinbryta (daclizumab)." AbbVie US LLC, North Chicago, IL.

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Zinbryta (daclizumab)." AbbVie US LLC, North Chicago, IL.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide